AATec Medical GmbH | WebDisclosure

Basculer en Français

8295	Companies
114850	Keywords
55292	Articles
62440	Press releases

Home
Companies
AATec Medical GmbH

BRIEF

published on 09/18/2024 at 10:05, 2 months 3 days ago

AATec Medical Welcomes Professor James Chalmers to Scientific Advisory Board

Scientific Advisory Board AATec Medical James Chalmers Bronchiectasis Recombinant AAT
BRIEF

published on 09/18/2024 at 10:05, 2 months 3 days ago

AATec Medical accueille le professeur James Chalmers au sein de son conseil consultatif scientifique

AATec Medical Conseil Consultatif Scientifique James Chalmers Bronchectasie AAT Recombinante
PRESS RELEASE

published on 09/18/2024 at 10:00, 2 months 3 days ago

AATec Medical Welcomes Professor James Chalmers to Scientific Advisory Board
AATec Medical welcomes Professor James Chalmers, a renowned expert in respiratory medicine, to its Scientific Advisory Board to advance product development in non-CF bronchiectasis

Scientific Advisory Board AATec Medical Professor James Chalmers Respiratory Medicine Non-CF Bronchiectasis
BRIEF

published on 07/24/2024 at 10:05, 3 months 28 days ago

AATec Medical Makes Significant Strides in First Year of Operations

Biotechnology Clinical Trials AATec Medical ATL-105 Inflammatory Lung Diseases
BRIEF

published on 07/24/2024 at 10:05, 3 months 28 days ago

AATec Medical réalise des progrès significatifs au cours de sa première année d'exploitation

Biotechnologie AATec Medical ATL-105 Essais Cliniques Maladies Pulmonaires Inflammatoires
PRESS RELEASE

published on 07/24/2024 at 10:00, 3 months 28 days ago

AATec Medical reports significant progress in company’s first year towards unlocking the therapeutic potential of AAT
AATec Medical reports significant progress in unlocking therapeutic potential of AAT for treating inflammatory lung diseases in its first year. Company advances lead candidate ATL-105 for NCFB

AATec Medical ATL-105 Inflammatory Lung Diseases Therapeutic Potential NCFB
BRIEF

published on 02/29/2024 at 09:30, 8 months 21 days ago

AATec Medical enrichit son Conseil Scientifique avec l'arrivée du Professeur Claus Franz Vogelmeier

AATec Medical Professeur Claus Franz Vogelmeier Maladies Inflammatoires Pulmonaires Conseil Scientifique Alpha-1 Antitrypsine
BRIEF

published on 02/29/2024 at 09:30, 8 months 21 days ago

AATec Medical enriches its Scientific Council with the arrival of Professor Claus Franz Vogelmeier

AATec Medical Professor Claus Franz Vogelmeier Inflammatory Lung Diseases Scientific Council Alpha-1 Antitrypsin
PRESS RELEASE

published on 02/29/2024 at 09:30, 8 months 21 days ago

AATec Medical appoints Professor Dr. Claus Franz Vogelmeier to the Scientific Advisory Board
AATec Medical appoints Prof. Dr. Claus Franz Vogelmeier, a renowned pulmonology expert, to its Scientific Advisory Board, enhancing expertise in inflammatory lung diseases. Visit www.aatec-medical.com for details

Scientific Advisory Board AATec Medical Inflammatory Lung Diseases Alpha-1 Antitrypsin Professor Dr. Claus Franz Vogelmeier
PRESS RELEASE

published on 02/06/2024 at 09:00, 9 months 15 days ago

AATec Medical starts collaboration with the German Federal Agency for Disruptive Innovation SPRIND for alpha-1 antitrypsin
AATec Medical collaborates with German Federal Agency for Disruptive Innovation SPRIND to develop ATL-105, a recombinant alpha-1 antitrypsin platform for respiratory diseases, including viral infections and inflammatory diseases

Respiratory Diseases AATec Medical German Federal Agency For Disruptive Innovation SPRIND ATL-105 Recombinant Alpha-1 Antitrypsin

Accesswire

Published on 11/21/2024 at 11:30, 27 minutes ago

FireFox Trenching Returns More High-Grade Gold at the Mustajärvi Gold Project in Lapland, Finland
Published on 11/21/2024 at 10:03, 1 hour 54 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 1 hour 57 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 2 hours 57 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 11 hours 22 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 11:30, 27 minutes ago

APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived
Published on 11/21/2024 at 11:01, 56 minutes ago

Original-Research: SMT Scharf AG (von Montega AG): Kaufen
Published on 11/21/2024 at 11:00, 57 minutes ago

First Patient Treated in Phase I/II Trial in Acute Myeloid and Acute Lymphoblastic Leukemia with Lu177-PentixaTher, Expanding the Evidence Base for Targeted Radiotherapy Approach
Published on 11/21/2024 at 10:56, 1 hour ago

ABO Energy closes sale for two Battery Projects in South Africa
Published on 11/21/2024 at 10:30, 1 hour 27 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024

Les Echos

Published on 11/21/2024 at 06:58, 4 hours 59 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 4 hours 59 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 4 hours 59 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 15 hours 50 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 16 hours 37 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE